Expanded Access Part 2 How

Expanded Access Part 2 How Information Guide

1. About on Expanded Access Part 2 How
2. Key Details
3. Recent Updates
4. Full Guide
5. Summary

About on Expanded Access Part 2 How

An overview on the submission process for emergency and non-emergency This is the fifth in a series of videos designed to let patients, caregivers, and patient advocates know that FDA wants to hear from ... FDA Chief Project Manager Monica Hughes provides step-by-step instructions on completing Form FDA 3926, a one-page form, ... This webinar provided a comprehensive understanding of the The first of our series of educational videos on pre-approval FDA Chief Project Manager Monica Hughes provides step-by-step instructions on completing Form FDA 3926 for follow-up ...

FDA Foundation board member Kay Holcombe, MS, and Lori Bickel, JD, Regulatory Counsel, FDA discuss the partnership ...

Key Details

Recent Updates

Expanded Access Part 3: How to Complete Form FDA 3926 for Initial Submissions

FDA's Expanded Access for Treatment Use

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers

Expanded Access To New Medicines: How it Works in the U.S.

Expanded Access Part 4: How to Complete Form FDA 3926 for Follow-Up Submissions

Overview of FDA's Expanded Access Program (13/14) REdI 2017

Expanded Access Care Webinar

Expanded Access discussion at the 2021 FDA Foundation Annual Meeting

Right to Try Act - Expanding Access to Experimental Brain Tumor Treatments

Full Guide

Data is compiled from public records and verified media reports.

Last Updated: June 22, 2026

Summary

Disclaimer: Disclaimer: Details estimates are based on publicly available data, media reports, and financial analysis. Actual numbers may vary.